<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p6.xml</sm:loc>
    <ifp:title>Basal Cell and Squamous Cell Skin Cancers Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p31.xml</sm:loc>
    <ifp:title>NMSC in Organ Transplant Recipients and Other High-Risk Groups</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p46.xml</sm:loc>
    <ifp:title>Melanoma Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p61.xml</sm:loc>
    <ifp:title>Point: Interferon-α for Adjuvant Therapy for Melanoma Patients</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p69.xml</sm:loc>
    <ifp:title>Counterpoint: The Case Against Adjuvant High-Dose Interferon-α for Melanoma Patients</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p74.xml</sm:loc>
    <ifp:title>Dermatofibrosarcoma Protuberans Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p80.xml</sm:loc>
    <ifp:title>Merkel Cell Carcinoma Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/2/1/article-p89.xml</sm:loc>
    <ifp:title>Treatment Options for Merkel Cell Carcinoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
